Navidea

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in the field of precision medicine, with its immunotargeting products designed to help identify undiscovered sites and pathways of disease, enabling improved diagnostic accuracy, clinical decision-making, targeted treatment, and ultimately, patient care.The company focuses on developing innovative immuno-diagnostic and immuno-therapeutic agents that can and will have an impact on individuals affected by devastating diseases such as cancer, autoimmune disorders, infectious diseases, and inflammation, as well as their families, doctors, and caregivers. For patients and physicians, we strive to provide innovative immuno-diagnostic agents and therapies to enhance patient care for serious illnesses. For investors, our goal is to achieve exceptional growth by focusing on the development of the innovative Manocept™ platform and driving efficient business processes. For our employees, we offer a culture centered on the direct contributions we make to the patients we serve, while providing an innovative development environment for breakthrough products.